Swiss CDMO Lonza is making a move to strengthen and speed up quality control testing with the purchase of French rapid ...
Alizé Pharma SAS, an Alizé Pharma group company specialized in the development of biopharmaceuticals to treat metabolic disorders and rare diseases, will present the results from two Phase I clinical ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback